Search

San Francisco-based DNA manufacturing technology startup Twist Bioscience announced this morning that it has raised another $33M in funding, bringing its total raised to $166M. Source of the new funding was not announced. The company said it will use the equity capital to further accelerate its business, plus expand its pharmaceutical discovery and data storage verticals.
posted on Monday, March 27, 2017

Related companies:
Twist Bioscience Corp

Related stories:
> Twist Bioscience Buys Genome Compiler
> Twist Bioscience Gains $50M More
> Twist Bioscience Gets $37M
> Twist Bioscience Adds $27M
> Twist Bioscience Gets $26M

---

silicontap.com Home